The DCC protein and prognosis in colorectal cancer
Cell Adhesion Molecules
Tumor Suppressor Proteins
DCC is a prognostic marker in patients with stage II or stage III colorectal cancer. In stage II colorectal carcinomas, the absence of DCC identifies a subgroup of patients with lesions that behave like stage III cancers. These findings may thus have therapeutic implications in this group of patients.